Philip T. Cagle, Randall J. Olsen, Bryce P. Portier, Hidehiro Takei, and David W. Bernard (2015) A New Ever-Evolving Paradigm. Archives of Pathology & Laboratory Medicine: April 2015, Vol. 139, No. 4, pp. 446-447.
SPECIAL SECTION—CANCER BIOMARKER UPDATE, PART I
Philip T. Cagle, MD; Randall J. Olsen, MD, PhD; Bryce P. Portier, MD, PhD; Hidehiro Takei, MD; David W. Bernard, MD, PhD
"Cancer biomarker testing is now a mainstay of 21st
century pathology practice, embracing the pathologist’s
role in patient selection for specific targeted therapies.
Pathologists, oncologists, and others require direction in
adapting to this new ever-evolving paradigm."
No comments:
Post a Comment